Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms

Microbes and Infection

Volumn 5, Issue 4, 2003, Pages 261-273

  Hoerauf, Achim ^a   Mand, Sabine ^a   Volkmann, Lars ^a   Büttner, Marcelle ^a   Marfo Debrekyei, Yeboah ^b   Taylor, Mark ^c   Adjei, Ohene ^b,d   Büttner, Dietrich W ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b Kumasi Centre for Collaborative Research   (Ghana)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Doxycycline; Filariasis; Immunohistology; Ivermectin; Onchocerciasis; Wolbachia

Indexed keywords

DOXYCYCLINE FOSFATEX; IVERMECTIN;

ADULT; ARTICLE; CONTROLLED STUDY; COST; DISEASE COURSE; EMBRYO DEVELOPMENT; FEMALE; FILARIA; GHANA; HUMAN; IMMUNOHISTOLOGY; KINETICS; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; NONHUMAN; ONCHOCERCA; ONCHOCERCIASIS; ONSET AGE; PARASITE TRANSMISSION; PRIORITY JOURNAL; REDUCTION; SPERMATOZOON; WOLBACHIA; WORM;

ANIMALIA; ONCHOCERCA; WOLBACHIA;

EID: 0037388065     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00026-1     Document Type: Article

References (46)

1. WHO, Onchocerciasis and its control. WHO Tech. Rep. Ser. 852:1995;1-103.
2. Hougard J.M., Alley E.S., Yameogo L., Dadzie K.Y., Boatin B.A. Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J. Infect. Dis. 184:2001;497-503.
3. Richards F.O., Boatin B., Sauerbrey M., Seketeli A. Control of onchocerciasis today: status and challenges. Trends Parasitol. 17:2001;558-563.
4. Albiez E.J., Walter G., Kaiser A., Ranque P., Newland H.S., White A.T., Greene B.M., Taylor H.R., Büttner D.W. Histological examination of onchocercomata after therapy with ivermectin. Trop. Med. Parasitol. 39:1988;93-99.
5. Campbell W.C. Ivermectin as an antiparasitic agent for use in humans. Annu. Rev. Microbiol. 45:1991;445-474.
6. Goa K.L., McTavish D., Clissold S.P. Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs. 42:1991;640-658.
7. Awadzi K., Addy E.T., Opoku N.O., Plenge-Bönig A., Büttner D.W. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole. Trop. Med. Parasitol. 46:1995;213-220.
8. Grant W. What is the real target for ivermectin resistance selection in Onchocerca volvulus? Parasitol. Today. 16:2000;458-459.
9. Prichard R. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol. 17:2001;445-453.
10. Richards F., Hopkins D., Cupp E. Programmatic goals and approaches to onchocerciasis. Lancet. 355:2000;1663-1664.
11. Abiose A., Homeida M., Liese B., Molyneux D., Remme H. Onchocerciasis control strategies. Lancet. 356:2000;1523-1524.
12. Alley W.S., van Oortmarssen G.G., Boatin B.B., Nagelkerke N.N., Plaisier A.A., Remme H.J., Lazdins J., Borsboom G.J., Habbema J.D. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health. 1:2001;12.
13. Bandi C., Anderson T.J., Genchi C., Blaxter M.L. Phylogeny of Wolbachia in filarial nematodes. Proc. R. Soc. Lond. B, Biol. Sci. 265:1998;2407-2413.
14. Taylor M., Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitol. Today. 15:1999;437-442.
15. Taylor M.J., Bandi C., Hoerauf A.M., Lazdins J. Wolbachia bacteria of filarial nematodes: a target for control? Parasitol. Today. 16:2000;179-180.
16. Hoerauf A., Walter R.D., Remme H., Lazdins J., Fleischer B. Call to consolidate achievements for onchocerciasis and lymphatic filariasis control. Trends Parasitol. 17:2001;566-567.
17. Final Report of the Conference on the Eradicability of Onchocerciasis: 2002;Atlanta, GA, USA. downloadable as PDF via http://www.cartercenter.org/.
18. Taylor M.J., Hoerauf A. A new approach to the treatment of filariasis. Curr. Opin. Infect. Dis. 14:2001;727-731.
19. Bandi C., Trees A.J., Brattig N.W. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases. Vet. Parasitol. 98:2001;215-238.
20. Hoerauf A., Nissen-Pähle K., Schmetz C., Henkle-Dührsen K., Blaxter M.L., Büttner D.W., Gallin M.Y., Al-Qaoud K.M., Lucius R., Fleischer B. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J. Clin. Invest. 103:1999;11-18.
21. Bandi C., McCall J.W., Genchi C., Corona S., Venco L., Sacchi L. Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int. J. Parasitol. 29:1999;357-364.
22. Hoerauf A., Volkmann L., Paehle K., Schmetz C., Autenrieth I., Büttner D.W., Fleischer B. Targeting of Wolbachia in Litomosoides sigmodontis: comparison of tetracycline with chloramphenicol, macrolides and ciprofloxacin. Trop. Med. Int. Health. 5:2000;275-279.
23. Townson S., Hutton D., Siemienska J., Hollick L., Scanlon T., Tagboto S.K., Taylor M.J. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Ann. Trop. Med. Parasitol. 94:2000;801-816.
24. Langworthy S., Renz A., Mackenstedt U., Henkle-Dührsen K., Bronsvoort M., Tanya V., Donnelly M., Trees A. Macrofilaricidal activity of tetracycline against the filarial nematode, Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc. Royal Soc. London Ser. B. 267:2000;1063-1069.
25. Hoerauf A., Volkmann L., Hamelmann C., Adjei O., Autenrieth I.B., Fleischer B., Büttner D.W. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet. 355:2000;1242-1243.
26. Hoerauf A., Mand S., Adjei O., Fleischer B., Büttner D.W. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet. 357:2001;1415-1416.
27. Hoerauf A., Adjei O., Büttner D.W. Antibiotics for the treatment of onchocerciasis and other filarial infections. Curr. Opin. Invest. Drugs. 3:2002;533-537.
28. Büttner D.W., Albiez E.J., von Essen J., Erichsen J. Histological examination of adult Onchocerca volvulus and comparison with the collagenase technique. Trop. Med. Parasitol. 39:1988;390-417.
29. Albiez E.J., Büttner D.W., Duke B.O. Diagnosis and extirpation of nodules in human onchocerciasis. Trop. Med. Parasitol. 39:1988;331-346.
30. Henkle-Dührsen K., Eckelt V., Wildenburg G., Blaxter M., Walter R.D. Gene structure, activity and localization of a catalase from intracellular bacteria in Onchocerca volvulus. Mol. Biochem. Parasitol. 96:1998;69-81.
31. Liebau E., Wildenburg G., Walter R.D., Henkle-Dührsen K. A novel type of glutathione S -transferase in Onchocerca volvulus. Infect. Immun. 62:1994;4762-4767.
32. Schulz-Key H., Albiez E.J., Büttner D.W. Isolation of living adult Onchocerca volvulus from nodules. Trop. Med. Parasitol. 28:1977;428-430.
33. Brattig N., Büttner D.W., Hoerauf A. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect. 3:2001;439-446.
34. St André A., Blackwell N.M., Hall L.R., Hoerauf A., Brattig N., Taylor M., Ford L., Hise A., Volkmann L., Lass J.H., Diaconu E., Pearlman E. A critical role for endosymbiotic Wolbachia bacteria and TLR4 signaling in the pathogenesis of river blindness. Science. 295:2002;1892-1895.
35. Fischer P., Büttner D.W., Bamuhiiga J., Williams S.A. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am. J. Trop. Med. Hyg. 58:1998;816-820.
36. Erttmann K.D., Gallin M.Y., Eggert P., Büttner D.W. Immunohistological studies on an Onchocerca volvulus ankyrin (EI). Trop. Med. Int. Health. 1:1996;558-574.
37. Franz M. The morphology of adult Onchocerca volvulus based on electron microscopy. Trop. Med. Parasitol. 39:1988;359-366.
38. Awadzi K., Attah S.K., Addy E.T., Opoku N.O., Quartey B.T. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients. Trans. R. Soc. Trop. Med. Hyg. 93:1999;189-194.
39. Kläger S. Investigations of enzymatically isolated male Onchocerca volvulus: qualitative and quantitative aspects of spermatogenesis. Trop. Med. Parasitol. 39:1988;441-445.
40. Chavasse D.C., Post R.J., Davies J.B., Whitworth J.A. Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Trop. Med. Parasitol. 44:1993;155-158.
41. Awadzi K., Hero M., Opoku O., Büttner D.W., Gilles H.M. The chemotherapy of onchocerciasis. XV. Studies with albendazole. Trop. Med. Parasitol. 42:1991;356-360.
42. Weyer F. Progresses in ecology and epidemiology of rickettsioses. Acta Trop. 35:1978;5-21.
43. de Wit D., Wootton M., Dhillon J., Mitchison D.A. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuber. Lung Dis. 76:1995;555-562.
44. Hu Y., Mangan J.A., Dhillon J., Sole K.M., Mitchison D.A., Butcher P.D., Coates A.R. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J. Bacteriol. 182:2000;6358-6365.
45. Pai S.R., Actor J.K., Sepulveda E., Hunter Jr R.L., Jagannath C. Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA. Microb. Pathog. 28:2000;335-342.
46. Awadzi K., Hero M., Opoku N.O., Addy E.T., Büttner D.W., Ginger C.D. The chemotherapy of onchocerciasis XVIII. Aspects of treatment with suramin. Trop. Med. Parasitol. 46:1995;19-26.